4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-027294
EVP, COO, HEAD OF COMMERCIAL sold 10,329 shares at $16.81 ($173,630)
- EVP, COO, HEAD OF COMMERCIAL acquired 19,826 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-11-17 | Option exercise | +9,913 | 62,521 | D | ||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-11-17 | Option exercise | +9,913 | 72,434 | D | ||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-11-19 | Sale | −10,329 | $16.81 | $173,630 | 62,105 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-11-17 | Option exercise · Restricted Stock Units | −9,913 | 9,913 | D | ||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-11-17 | Option exercise · Restricted Stock Units | −9,913 | 9,913 | D | ||
| Open-market sales · 10,329 sh · avg $16.81 · $173,630 | |||||||
Loading xslF345X05/form4-11202024_011138.xml…